Patents by Inventor Florence Frager

Florence Frager has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11180806
    Abstract: The present invention relates to a process for determining in vitro the immune status of an individual according to which: (a) a blood sample from the individual is provided, (b) at least two reagents specific to at least two products of expression of at least two target genes are provided; (c) the expression of said at least two target genes is determined, and (d) the expression of said at least two target genes respectively is compared with a reference expression, with a change in the expression of said at least two target genes relative to their reference expression indicating that the individual's immune status has changed, and a correlation between the expression of said at least two target genes with their reference expression indicating that the individual's immune status is normal; as well as a kit for determining said immune status of the individual.
    Type: Grant
    Filed: April 24, 2018
    Date of Patent: November 23, 2021
    Assignees: BIOMERIEUX, HOSPICES CIVILS DE LYON (HCL)
    Inventors: Fanny Davin, Alain Lepape, Guillaume Monneret, Florence Frager
  • Publication number: 20180312921
    Abstract: The present invention relates to a process for determining in vitro the immune status of an individual according to which: (a) a blood sample from the individual is provided, (b) at least two reagents specific to at least two products of expression of at least two target genes are provided; (c) the expression of said at least two target genes is determined, and (d) the expression of said at least two target genes respectively is compared with a reference expression, with a change in the expression of said at least two target genes relative to their reference expression indicating that the individual's immune status has changed, and a correlation between the expression of said at least two target genes with their reference expression indicating that the individual's immune status is normal; as well as a kit for determining said immune status of the individual.
    Type: Application
    Filed: April 24, 2018
    Publication date: November 1, 2018
    Applicants: BIOMERIEUX, HOSPICES CIVILS DE LYON (HCL)
    Inventors: Fanny DAVIN, Alain LEPAPE, Guillaume MONNERET, Florence FRAGER
  • Patent number: 9982298
    Abstract: The present invention relates to a process for determining in vitro the immune status of an individual according to which: (a) a blood sample from the individual is provided, (b) at least two reagents specific to at least two products of expression of at least two target genes are provided; (c) the expression of said at least two target genes is determined, and (d) the expression of said at least two target genes respectively is compared with a reference expression, with a change in the expression of said at least two target genes relative to their reference expression indicating that the individual's immune status has changed, and a correlation between the expression of said at least two target genes with their reference expression indicating that the individual's immune status is normal; as well as a kit for determining said immune status of the individual.
    Type: Grant
    Filed: January 27, 2012
    Date of Patent: May 29, 2018
    Assignees: BIOMERIEUX, HOSPICES CIVILS DE LYON
    Inventors: Fanny Davin, Alain Lepape, Guillaume Monneret, Florence Frager
  • Publication number: 20130316930
    Abstract: The present invention relates to a process for determining in vitro the immune status of an individual according to which: (a) a blood sample from the individual is provided, (b) at least two reagents specific to at least two products of expression of at least two target genes are provided; (c) the expression of said at least two target genes is determined, and (d) the expression of said at least two target genes respectively is compared with a reference expression, with a change in the expression of said at least two target genes relative to their reference expression indicating that the individual's immune status has changed, and a correlation between the expression of said at least two target genes with their reference expression indicating that the individual's immune status is normal; as well as a kit for determining said immune status of the individual.
    Type: Application
    Filed: January 27, 2012
    Publication date: November 28, 2013
    Applicants: HOSPICES CIVILS DE LYON (HCL), BIOMERIEUX
    Inventors: Fanny Davin, Alain Lepape, Guillaume Monneret, Florence Frager